World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
134
Citations
85234
World Ranking
2119
National Ranking
1197

Dean J. Kereiakes publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Dean J. Kereiakes sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 789 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Dean J. Kereiakes D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Dean J. Kereiakes sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 134 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Dean J. Kereiakes is affiliated with The Christ Hospital Health Network in the United States. Their research is primarily situated within the field of Medicine, focusing on Surgery, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, and Epidemiology.

Their work covers several main topics, including:

  • Coronary Interventions and Diagnostics
  • Cardiac Valve Diseases and Treatments
  • Cardiac Imaging and Diagnostics
  • Infective Endocarditis Diagnosis and Management
  • Peripheral Artery Disease Management
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Aortic Disease and Treatment Approaches

Frequent co-authors collaborating with Dean J. Kereiakes include Gregg W. Stone, Santiago García, Richard Shlofmitz, Ziad A. Ali, and Puvi Seshiah.

The scientist has contributed extensively to various publication venues, notably:

  • Journal of the American College of Cardiology
  • Journal of the Society for Cardiovascular Angiography & Interventions
  • JACC: Cardiovascular Interventions
  • Cardiovascular Revascularization Medicine
  • European Heart Journal

Selected recent publications by Dean J. Kereiakes include:

  • Principles of Intravascular Lithotripsy for Calcific Plaque Modification, 2021, JACC: Cardiovascular Interventions
  • Intravascular Lithotripsy for Treatment of Calcified Coronary Lesions, 2021, JACC: Cardiovascular Interventions

Other notable papers where Dean J. Kereiakes is not the lead author but are part of the recent literature include:

  • Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement, 2020, New England Journal of Medicine
  • Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease, 2020, Journal of the American College of Cardiology
  • Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis, 2021, European Heart Journal

Best Publications

  • ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina)

    Eugene Braunwald;Elliott M. Antman;John W. Beasley;Robert M. Califf

  • Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

    Jeffrey W. Moses;Martin B. Leon;Jeffrey J. Popma;Peter J. Fitzgerald

  • Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.

    Martin B Leon;Craig R. Smith;Michael J. Mack;Michael J. Mack;Rajendra Makkar

  • ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article

    Eugene Braunwald;Elliott M Antman;John W Beasley;Robert M Califf

  • Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

    Laura Mauri;Dean J. Kereiakes;Robert W. Yeh;Priscilla Driscoll-Shempp

  • Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease The ONSET/OFFSET Study

    Paul A. Gurbel;Kevin P. Bliden;Kathleen Butler;Udaya S. Tantry

  • Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate

    Laurent Bonello;Udaya S. Tantry;Rossella Marcucci;Ruediger Blindt

  • ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).

    Eugene Braunwald;Elliott M Antman;John W Beasley;Robert M Califf

  • Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention: REPLACE-2 Randomized Trial

    A. Michael Lincoff;John A. Bittl;Robert A. Harrington;Frederick Feit

  • Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

    James J Ferguson;Robert M Califf;Elliott M Antman;Marc Cohen

  • Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis

    Vinod H. Thourani;Susheel Kodali;Raj R. Makkar;Howard C. Herrmann

  • A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction.

    Eric J. Topol;Robert M. Califf;Barry S. George;Dean J. Kereiakes

  • Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

    Gregg W. Stone;Ali Rizvi;William Newman;Kourosh Mastali

  • ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary

    Jr Smith;J. T. Dove;A. K. Jacobs;J. W. Kennedy

  • Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.

    Robert W. Yeh;Robert W. Yeh;Eric A. Secemsky;Dean J. Kereiakes;Sharon-Lise T. Normand

  • ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty) Endorsed by the Society for Cardiac Angiography and Interventions

    Sidney C. Smith;James T. Dove;Alice K. Jacobs;J. Ward Kennedy

  • Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease, SAR236553/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy.

    James M. McKenney;Michael J. Koren;Dean J. Kereiakes;Corinne Hanotin

  • Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease

    Stephen G. Ellis;Dean J. Kereiakes;D. Christopher Metzger;Ronald P. Caputo

  • ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)

    F. J. Hildner;E. Braunwald;E. M. Antman;J. W. Beasley

  • Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. Commentary

    Eric L. Eisenstein;Kevin J. Anstrom;David F. Kong;Linda K. Shaw

Frequent Co-Authors

Gregg W. Stone
Gregg W. Stone Icahn School of Medicine at Mount Sinai
Eric J. Topol
Eric J. Topol Scripps Research Institute
Laura Mauri
Laura Mauri University of Milan
Stephen G. Ellis
Stephen G. Ellis Cleveland Clinic
Jeffrey J. Popma
Jeffrey J. Popma Beth Israel Deaconess Medical Center
Robert M. Califf
Robert M. Califf Duke University
Donald E. Cutlip
Donald E. Cutlip Beth Israel Deaconess Medical Center
Patrick W. Serruys
Patrick W. Serruys University of Galway
A. Michael Lincoff
A. Michael Lincoff Cleveland Clinic
Alexandra J. Lansky
Alexandra J. Lansky Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens doors to multiple career pathways beyond becoming a physician. A popular option is health administration, where students can manage healthcare facilities or departments. For those interested, there are affordable online mha programs that provide flexibility and help minimize educational costs.

If advancing clinical skills is your goal, earning a Doctor of Nursing Practice (DNP) or a Doctor of Pharmacy (PharmD) can be beneficial. Many professionals consider the cheapest dnp programs to balance affordability with quality education. PharmD candidates can also now opt for reputable online pharmd pathways that are flexible for working students.

Another expanding field is health information management, which combines technology and healthcare. Earning relevant certifications, such as the RHIA, can boost your career prospects—and there are several rhia certification programs online to consider.

Each option provides strong job prospects and opportunities to specialize within the dynamic world of healthcare, all while allowing you to study from anywhere.

Best Scientists Citing Dean J. Kereiakes

Trending Scientists

Recently Published Articles